Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
The 1999 Institute of Medicine (IOM) report, “To Err Is Human,” brought patient safety to the forefront with its alarming findings, most jarringly encapsulated in its conclusion that medical error-related deaths in the United States are the equivalent of crashing one jumbo jet per day. L.T. Kohn, J.M. Corrigan, and M.S. Donaldson, eds., “To Err Is Human: Building a Safer Health System” (National Academies Press, 1999). According to the IOM's report, one factor underlying the high rate of medical errors has been a reluctance on the part of providers to identify and address medical errors due to concerns that such information would be used against them in medical malpractice lawsuits or professional disciplinary actions.
The Patient Safety and Quality Improvement Act
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.